Mathieu Clusaz

Mathieu Clusaz is currently the Chief Operating Officer at the Centre des Thérapies Expérimentales at CHUV, where they lead a team of over 50 individuals in the production of Cimzia. With a background in the biotech and chemistry industries, Mathieu has held various roles, including Manufacturing Operational Support Manager at Merck Group and Upstream Manager at UCB. They possess a strong focus on leadership, team creation, and process improvement, and are passionate about advancing technologies across multiple fields. Mathieu holds multiple degrees, including a Master's from Haute Ecole de la Communauté française and a BSc from Université Paris-Est Marne-la-Vallée.